InvestorsHub Logo
Followers 15
Posts 860
Boards Moderated 0
Alias Born 05/14/2012

Re: blackpantherz post# 19329

Tuesday, 01/28/2014 6:30:04 AM

Tuesday, January 28, 2014 6:30:04 AM

Post# of 30046
Research Abstract Presentations in Scientific Conferences

The utility of DR-70Ò, a novel blood biomarker, in the early detection of lung cancer. Motamed-Khorasani A, Beart R. 2012 American Society of Clinical Oncology (ASCO). Chicago, IL; June 01–June 05, 2012.

Combined DR-70Ò and CEA Testing is advantageous Over CEA Alone in the Detection of colorectal cancer and specifically the Right-Sided type. Motamed-Khorasani A, Beart R. 2012 American Society of Colon and Rectal Surgeons Meeting (ASCRS). San Antonio, TX; June 02-06, 2012.

Further validation of DR-70Ò blood biomarker in the early detection of non-small cell lung cancer. Motamed-Khorasani A, Etemadi H. 2012 3rd European Lung Cancer Conference (ELCC). Geneva, Switzerland; April 18-April 21, 2012.

Clinical Advantages of Combined DR-70Ò and CEA Testing Over CEA Alone in the Detection of Right-Sided Colorectal Cancer. Motamed-Khorasani A, Small-Howard A, Beart R. 2012 American Association of Cancer Research (AACR). Chicago, IL; March 31-April 4, 2012.

A novel cost-effective strategy for colorectal cancer screening with higher patient compliance. Motamed-Khorasani A, Small-Howard A, Beart R. 2012 Gastrointestinal Cancers Symposium (ASCO). San Francisco, CA, USA; January 19-21, 2012.

A new strategy for the early detection of colorectal cancer recurrence. Motamed-Khorasani A, Small-Howard A, Etemadi H, Beart H. 2012 Gastrointestinal Cancers Symposium (ASCO). San Francisco, CA, USA; January 19-21, 2012.

The Pros and Cons of Tumor Markers. BIT’s 4th World Cancer Congress, track 5-2 (Cancer Diagnostics, Therapy and Clinical Update). A Motamed-Khorasani (Invited Session Chair & Speaker). Dalian, China; May 22-25, 2011.

The Validation of DR-70 Efficiency in Early Detection of Lung Cancer (Abstract #515). A. Motamed-Khorasani, R Grimes, DF Weber. European Multidisciplinary Conference in Thoracic Oncology (EMCTO). Lugano, Switzerland; February 2011.

DR-70 Tumor Marker for Colorectal Cancer Treatment and/or recurrence Monitoring. A. Motamed-Khorasani, A Small-Howard. National Comprehensive Cancer Network (NCCN) Congress Series: Gastrointestinal Cancers. Philadelphia, PA, USA; September 2010.

Onko-Sure DR-70 IVD Cancer Test. A. Motamed-Khorasani, C Gee. Annual Meeting for American Association for Clinical Chemistry (AACC). Anaheim, CA, USA; July 2010.

Onko-Sure DR-70 IVD Cancer Test. A. Motamed-Khorasani, C Gee. 10th Annual Meeting of American Society of Clinical Oncology (ASCO). Chicago, IL, USA; June 4-8, 2010.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.